Market revenue in 2023 | USD 51.2 million |
Market revenue in 2030 | USD 63.8 million |
Growth rate | 3.2% (CAGR from 2023 to 2030) |
Largest segment | Vascular |
Fastest growing segment | Non-vascular Stents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Vascular, Non-vascular Stents |
Key market players worldwide | Abbott Laboratories, B. Braun, BIOTRONIK, Biosensors, Boston Scientific Corp, Elixirr International PLC Ordinary Shares, Medtronic PLC, MicroPort Scientific Corp, Stryker Corp, Terumo Corp, W.L. Gore & Associates, BD, Conmed Corp, Meril Life |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stents market will help companies and investors design strategic landscapes.
Vascular was the largest segment with a revenue share of 88.48% in 2023. Horizon Databook has segmented the UAE stents market based on vascular, non-vascular stents covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE stents market , including forecasts for subscribers. This country databook contains high-level insights into UAE stents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account